{{Rsnum
|rsid=1131445
|Gene=IL16
|Chromosome=15
|position=81309441
|Orientation=plus
|GMAF=0.3122
|Gene_s=IL16
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 8.0 | 54.9 | 37.2
| HCB | 6.6 | 43.1 | 50.4
| JPT | 11.5 | 35.4 | 53.1
| YRI | 8.8 | 42.2 | 49.0
| ASW | 10.5 | 43.9 | 45.6
| CHB | 6.6 | 43.1 | 50.4
| CHD | 10.1 | 43.1 | 46.8
| GIH | 5.9 | 33.7 | 60.4
| LWK | 3.6 | 46.4 | 50.0
| MEX | 1.7 | 25.9 | 72.4
| MKK | 6.4 | 42.3 | 51.3
| TSI | 15.7 | 50.0 | 34.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=23195133
|Title=The Association of Interleuin-16 Gene Polymorphisms with susceptibility of coronary artery disease
}}

{{PMID Auto
|PMID=23881440
|Title=Association between interleukin 6 and interleukin 16 gene polymorphisms and coronary heart disease risk in a Chinese population
}}

{{PMID Auto
|PMID=24061634
|Title=Genetic variation in IL-16 miRNA target site and time to prostate cancer diagnosis in African-American men
|OA=1
}}

{{PMID Auto
|PMID=24353682
|Title=Association between Polymorphisms in IL-16 Genes and Coronary Heart Disease risk
|OA=1
}}

{{PMID Auto
|PMID=18394967
|Title=Association of the interleukin (IL)-16 gene polymorphisms with Graves' disease.
}}

{{PMID Auto
|PMID=24175812
|Title=Variants of interleukin-16 associated with gastric cancer risk
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}